HIF1A and neoplasm: Restricted blood supply to a rapidly expanding tumour leads to hypoxic areas, and Hypoxia-inducible factor-1 (HIF-1) expression has been correlated with poorer clinical outcomes, as it confers resistance to apoptosis of tumour cells [30].